Does USTEKINUMAB Cause Device deployment issue? 639 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 639 reports of Device deployment issue have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.8% of all adverse event reports for USTEKINUMAB.
639
Reports of Device deployment issue with USTEKINUMAB
0.8%
of all USTEKINUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Device deployment issue From USTEKINUMAB?
Of the 639 reports, 5 (0.8%) required hospitalization.
Is Device deployment issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 639 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Device deployment issue?
ETONOGESTREL (3,621)
GOLIMUMAB (1,265)
GUSELKUMAB (778)
COPPER (768)
LEVONORGESTREL (718)
SUMATRIPTAN (292)
PEGFILGRASTIM (163)
ABATACEPT (131)
SOMATROPIN (130)
CARBIDOPA\LEVODOPA (88)
Which USTEKINUMAB Alternatives Have Lower Device deployment issue Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE